Levels of the wake-promoting neuropeptide hypocretin-1 have also been reported to be reduced in AD, as are the levels of hypocretin-1 neurons [43], which may be one of the mechanisms that cause prolonged sleep duration time in AD patients. Here, HCRT is linked to Alzheimer disease.